Stock Analysis

Is A Blocked Aquarion Sale And New Board Voice Altering The Investment Case For Eversource Energy (ES)?

  • Eversource Energy recently held a board meeting where it approved a quarterly dividend of US$0.7525 per share and elected veteran telecom executive W. Robert “Bob” Mudge to its Board of Trustees, effective January 1, 2026, with roles on the Audit and Finance and Risk Management Committees.
  • These governance moves come as the company reassesses its plans after Connecticut regulators blocked the more than US$2.00 billion sale of its Aquarion water utility business, a decision that directly affects its balance sheet and capital allocation options.
  • We’ll now examine how the blocked Aquarion sale reshapes Eversource’s investment narrative, particularly around balance sheet flexibility and future earnings visibility.

Uncover the next big thing with financially sound penny stocks that balance risk and reward.

Eversource Energy Investment Narrative Recap

To own Eversource Energy, you need to be comfortable with a regulated utility that is working through balance sheet pressures while continuing to prioritize its dividend and core electric and gas networks. The blocked Aquarion sale directly affects the main near term catalyst of strengthening the balance sheet and heightens the key risk around regulatory and financing outcomes, but the latest dividend decision and board changes do not by themselves materially change that risk profile.

The most relevant recent announcement here is the affirmed quarterly dividend of US$0.7525 per share, payable on December 31, 2025. Keeping the payout intact, even after the Aquarion decision, underlines how dependent the current investment case is on stable cash generation and eventual progress on other balance sheet levers, such as storm cost securitization and ongoing access to capital at acceptable terms.

However, investors should be aware that if storm cost securitization in Connecticut is delayed or constrained, it could...

Read the full narrative on Eversource Energy (it's free!)

Eversource Energy's narrative projects $14.8 billion revenue and $2.1 billion earnings by 2028.

Uncover how Eversource Energy's forecasts yield a $72.93 fair value, a 8% upside to its current price.

Exploring Other Perspectives

ES 1-Year Stock Price Chart
ES 1-Year Stock Price Chart

Four fair value estimates from the Simply Wall St Community span a wide range, from US$52 to about US$222 per share, showing how far apart individual views can be. Against that backdrop, the blocked Aquarion sale and ongoing regulatory uncertainty around balance sheet repair may be key reasons to compare several of these perspectives before deciding how Eversource fits into your portfolio.

Explore 4 other fair value estimates on Eversource Energy - why the stock might be worth 23% less than the current price!

Build Your Own Eversource Energy Narrative

Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.

Seeking Other Investments?

Don't miss your shot at the next 10-bagger. Our latest stock picks just dropped:

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Mobile Infrastructure for Defense and Disaster

The next wave in robotics isn't humanoid. Its fully autonomous towers delivering 5G, ISR, and radar in under 30 minutes, anywhere.

Get the investor briefing before the next round of contracts

Sponsored On Behalf of CiTech

Valuation is complex, but we're here to simplify it.

Discover if Eversource Energy might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

About NYSE:ES

Eversource Energy

A public utility holding company, engages in the energy delivery business.

Established dividend payer and good value.

Weekly Picks

WO
MGPI logo
woodworthfund on MGP Ingredients ·

THE KINGDOM OF BROWN GOODS: WHY MGPI IS BEING CRUSHED BY INVENTORY & PRIMED FOR RESURRECTION

Fair Value:US$4034.1% undervalued
22 users have followed this narrative
4 users have commented on this narrative
5 users have liked this narrative
DO
Double_Bubbler
EVTL logo
Double_Bubbler on Vertical Aerospace ·

Why Vertical Aerospace (NYSE: EVTL) is Worth Possibly Over 13x its Current Price

Fair Value:US$6089.9% undervalued
23 users have followed this narrative
3 users have commented on this narrative
17 users have liked this narrative
TI
TickerTickle
ORCL logo
TickerTickle on Oracle ·

The Quiet Giant That Became AI’s Power Grid

Fair Value:US$389.8149.0% undervalued
43 users have followed this narrative
4 users have commented on this narrative
8 users have liked this narrative

Updated Narratives

IM
HOH logo
Imthetxarbi on High Arctic Overseas Holdings ·

Deep Value Multi Bagger Opportunity

Fair Value:CA$471.8% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
AG
Agricola
EXN logo
Agricola on Excellon Resources ·

A case for CA$31.80 (undiluted), aka 8,616% upside from CA$0.37 (an 86 bagger!).

Fair Value:CA$31.898.8% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
ST
stuart_roberts
UNCY logo
stuart_roberts on Unicycive Therapeutics ·

Unicycive Therapeutics (Nasdaq: UNCY) – Preparing for a Second Shot at Bringing a New Kidney Treatment to Market (TEST)

Fair Value:US$21.5370.2% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

TH
TheWallstreetKing
MVIS logo
TheWallstreetKing on MicroVision ·

MicroVision will explode future revenue by 380.37% with a vision towards success

Fair Value:US$6098.4% undervalued
120 users have followed this narrative
11 users have commented on this narrative
22 users have liked this narrative
AN
AnalystConsensusTarget
NVDA logo
AnalystConsensusTarget on NVIDIA ·

NVDA: Expanding AI Demand Will Drive Major Data Center Investments Through 2026

Fair Value:US$250.3927.7% undervalued
963 users have followed this narrative
6 users have commented on this narrative
25 users have liked this narrative
RO
RockeTeller
SCZ logo
RockeTeller on Santacruz Silver Mining ·

Crazy Undervalued 42 Baggers Silver Play (Active & Running Mine)

Fair Value:CA$8683.3% undervalued
78 users have followed this narrative
8 users have commented on this narrative
21 users have liked this narrative